J. M. Cendros

Pharmacokinetic profile of lanreotide Autogel^® in patients with acromegaly after four deep subcutaneous injections of 60, 90 or 120 mg every 28 days

Marcello D. Bronstein, Nina Rosa de Castro Musolino, Raquel S. Jallad et al. · Clinical Endocrinology · 2005 · 54 citations

Therapeutic Drug Monitoring, Translational Medicine, Subcutaneous Injections +12

Population Pharmacokinetics of High-Dose Methotrexate After Intravenous Administration in Pediatric Patients With Osteosarcoma

Helena Colom, Rosa Farré Farré, Dolors Soy et al. · Therapeutic Drug Monitoring · 2009 · 43 citations

Phase I dose-finding study and a pharmacokinetic/pharmacodynamic analysis of the neutropenic response of intravenous diflomotecan in patients with advanced malignant tumours

Iñaki F. Trocóniz, Marı́a J. Garrido, Cristina Segura et al. · Cancer Chemotherapy and Pharmacology · 2005 · 36 citations

Dose-finding Study, Medicine, Pharmacology +7

Pharmacokinetic/Pharmacodynamic Model of the Testosterone Effects of Triptorelin Administered in Sustained Release Formulations in Patients with Prostate Cancer

Elba Romero, Nieves Vélez de Mendizábal, J. M. Cendros et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 32 citations

Population Pharmacokinetic Analysis of Lanreotide Autogel® in Healthy Subjects

Iñaki F. Trocóniz, J. M. Cendros, Concepción Peraire et al. · Clinical Pharmacokinetics · 2008 · 32 citations · Full text

Translational Medicine, Healthy Subjects, Clinical Therapeutic +4